3//SEC Filing
ALS Invest 1 B.V. 3
Accession 0000899243-22-016836
CIK 0001658551other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:42 PM ET
Size
6.0 KB
Accession
0000899243-22-016836
Insider Transaction Report
Form 3
ALS Invest 1 B.V.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (1,129,386 underlying)Series B Preferred Stock
→ Common Stock (4,826,503 underlying)
Footnotes (2)
- [F1]Each share of Series A and Series B preferred stock (collectively the "Preferred Stock") is convertible on a one-for-one basis into Common Stock at any time at the election of the Reporting Person and will automatically convert upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 without payment or further consideration. The Preferred Stock has no expiration date.
- [F2]The Reporting Person is managed by SUNU Ventures BV. Felix-Andre von Coerper is the sole corporate director of SUNU Ventures BV and has voting and dispositive power with respect to the securities held by the Reporting Person.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001920501
Filing Metadata
- Form type
- 3
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:42 PM ET
- Size
- 6.0 KB